As a component of the MAPK signaling cascade, MK5 has been implicated in various neurological disorders, including Alzheimer's disease [28], Parkinson's disease [29] and autoimmune encephalomyelitis [30]. This evidence concerns the gene MAPKAPK5 and nervous system disorder.